Patents by Inventor Lora Eshkar-Sebban

Lora Eshkar-Sebban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ISOLATED POLYPEPTIDES OF CD44 AND USES THEREOF
    Publication number: 20230212261
    Abstract: Isolated polypeptides of CD44 are provided. Accordingly, there is provided an isolated polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-3. Also provided is an isolated end-capping modified polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1-3, wherein the modified polypeptide comprises an anti-inflammatory activity. Also provided are compositions of matter, fusion proteins and pharmaceutical compositions and their use in the treatment of inflammatory disease.
    Type: Application
    Filed: December 20, 2022
    Publication date: July 6, 2023
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: David NAOR, Lora ESHKAR-SEBBAN, Keren-Or AMAR, Shmuel COHEN
  • Isolated polypeptides of CD44 and uses thereof
    Patent number: 11560417
    Abstract: Isolated polypeptides of CD44 are provided. Accordingly, there is provided an isolated polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-3. Also provided is an isolated end-capping modified polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1-3, wherein the modified polypeptide comprises an anti-inflammatory activity. Also provided are compositions of matter, fusion proteins and pharmaceutical compositions and their use in the treatment of inflammatory disease.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: January 24, 2023
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: David Naor, Lora Eshkar-Sebban, Keren-Or Amar, Shmuel Cohen
  • ISOLATED POLYPEPTIDES OF CD44 AND USES THEREOF
    Publication number: 20200181234
    Abstract: Isolated polypeptides of CD44 are provided. Accordingly, there is provided an isolated polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-3. Also provided is an isolated end-capping modified polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1-3, wherein the modified polypeptide comprises an anti-inflammatory activity. Also provided are compositions of matter, fusion proteins and pharmaceutical compositions and their use in the treatment of inflammatory disease.
    Type: Application
    Filed: February 18, 2020
    Publication date: June 11, 2020
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: David NAOR, Lora ESHKAR-SEBBAN, Keren-Or AMAR, Shmuel COHEN
  • Isolated polypeptides of CD44 and uses thereof
    Patent number: 10611819
    Abstract: Isolated polypeptides of CD44 are provided. Accordingly, there is provided an isolated polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-3. Also provided is an isolated end-capping modified polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1-3, wherein the modified polypeptide comprises an anti-inflammatory activity. Also provided are compositions of matter, fusion proteins and pharmaceutical compositions and their use in the treatment of inflammatory disease.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: April 7, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: David Naor, Lora Eshkar-Sebban, Keren-Or Amar, Shmuel Cohen
  • ISOLATED POLYPEPTIDES OF CD44 AND USES THEREOF
    Publication number: 20170218045
    Abstract: Isolated polypeptides of CD44 are provided. Accordingly, there is provided an isolated polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-3. Also provided is an isolated end-capping modified polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1-3, wherein the modified polypeptide comprises an anti-inflammatory activity. Also provided are compositions of matter, fusion proteins and pharmaceutical compositions and their use in the treatment of inflammatory disease.
    Type: Application
    Filed: July 15, 2015
    Publication date: August 3, 2017
    Inventors: David NAOR, Lora ESHKAR-SEBBAN, Keren-Or AMAR, Shmuel COHEN
  • MEANS AND METHODS FOR ENHANCING WEIGHT GAIN IN POULTRY
    Publication number: 20150099002
    Abstract: The present invention relates to means and methods for enhancing intestinal function in poultry, leading to an increase in food conversion ratio and in total weight gain. Particularly, the present invention relates to insulin-containing feed formulations enhancing intestinal function and weight gain in poultry.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 9, 2015
    Inventors: Naim Shehadeh, Lora Eshkar-Sebban, Aviv Hanien, Sharon Devir
  • GROWTH ENHANCEMENT OF INFANTS
    Publication number: 20150086622
    Abstract: The present invention relates to compositions and methods for enhancing the growth of infants. Particularly, the present invention discloses the use of insulin for promoting the growth of low birth weight infants, including preterm infants and small for gestational age (SGA) infants over the expected rate.
    Type: Application
    Filed: April 17, 2013
    Publication date: March 26, 2015
    Inventors: Naim Shehadeh, Aviv Hanien, Chen Porat, Raanan Shamir, Lora Eshkar-Sebban, Michal Devir, Michal Olshansky
  • MEANS AND METHODS FOR ENHANCING WEIGHT GAIN IN POULTRY
    Publication number: 20100233274
    Abstract: The present invention relates to means and methods for enhancing intestinal function in poultry, leading to an increase in food conversion ratio and in total weight gain. Particularly, the present invention relates to insulin-containing feed formulations enhancing intestinal function and weight gain in poultry.
    Type: Application
    Filed: June 10, 2008
    Publication date: September 16, 2010
    Inventors: Naim Shehadeh, Lora Eshkar-Sebban, Aviv Hanien, Sharon Devir